Eucalyptol

Identification

Summary

Eucalyptol is a common ingredient in mouthwash and cosmetics derived naturally from the eucalyptus plant that is frequently used to to improve symptoms of airway mucus hypersecretion.

Brand Names
Listerine Antiseptic
Generic Name
Eucalyptol
DrugBank Accession Number
DB03852
Background

Eucalyptol is naturally produced cyclic ether and monoterpenoid. Eucalyptol is an ingredient in many brands of mouthwash and cough suppressant. It controls airway mucus hypersecretion and asthma via anti-inflammatory cytokine inhibition. Eucalyptol is an effective treatment for nonpurulent rhinosinusitis. Eucalyptol reduces inflammation and pain when applied topically. It kills leukaemia cells in vitro.

Type
Small Molecule
Groups
Experimental, Nutraceutical
Structure
Weight
Average: 154.2493
Monoisotopic: 154.135765198
Chemical Formula
C10H18O
Synonyms
  • 1,8-cineol
  • 1,8-Cineole
  • 1,8-epoxy-p-menthane
  • 1,8-oxido-p-menthane
  • Cajeputol
  • Cineole
  • Eucalyptol
  • Zineol

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Prophylaxis ofGingivitis••• •••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Hover over products below to view reaction partners

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Oral, rat LD50: 2480 mg/kg

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Germ Free ARIALiquid1.2 g/100mLTopicalOmega Vision Co., Ltd.2022-09-24Not applicableUS flag
Rosatra Synergy for treatment of Acne RosaceaOil0.7 g/50gTopicalPhytopia Co., Ltd.2016-02-29Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
365 Whole Foods Market Anticavity/Antigingivitis MouthwashEucalyptol (0.92 mg/1mL) + Menthol (0.42 mg/1mL) + Methyl salicylate (0.6 mg/1mL) + Sodium fluoride (0.1 mg/1mL) + Thymol (0.64 mg/1mL)MouthwashDentalWhole Foods Market, Inc.2022-01-31Not applicableUS flag
365 Whole Foods Market Antigingivitis MouthwashEucalyptol (0.92 mg/1mL) + Menthol (0.42 mg/1mL) + Methyl salicylate (0.6 mg/1mL) + Thymol (0.64 mg/1mL)MouthwashDentalWhole Foods Market, Inc.2022-01-31Not applicableUS flag
Advanced AntisepticEucalyptol (.092 kg/100L) + Menthol (.042 kg/100L) + Methyl salicylate (.060 kg/100L) + Thymol (.064 kg/100L)MouthwashOralDemoulas Super Markets, Inc2010-07-22Not applicableUS flag
Advanced AntisepticEucalyptol (.042 mL/100L) + Menthol (.042 mL/100L) + Methyl salicylate (.060 mL/100L) + Thymol (.064 mL/100L)MouthwashOralWakefern Food Corporation2010-11-24Not applicableUS flag
Advanced Antiseptic CitrusEucalyptol (.092 mL/100L) + Menthol (.042 mL/100L) + Methyl salicylate (.060 mL/100L) + Thymol (.042 mL/100L)MouthwashOralH E B2010-10-15Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Antiseptic RinseEucalyptol (.092 kg/100L) + Menthol (.042 kg/100L) + Methyl salicylate (.060 kg/100L) + Thymol (.064 kg/100L)MouthwashOralMeijer2006-08-08Not applicableUS flag
Germ Free ARIAEucalyptol (1.2 g/100mL)LiquidTopicalOmega Vision Co., Ltd.2022-09-24Not applicableUS flag

Categories

ATC Codes
R05CA13 — Cineole
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as oxanes. These are compounds containing an oxane (tetrahydropyran) ring, which is a six-member saturated aliphatic heterocycle with one oxygen atom and five carbon atoms.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Oxanes
Sub Class
Not Available
Direct Parent
Oxanes
Alternative Parents
Oxacyclic compounds / Dialkyl ethers / Hydrocarbon derivatives
Substituents
Aliphatic heteropolycyclic compound / Dialkyl ether / Ether / Hydrocarbon derivative / Organic oxygen compound / Organooxygen compound / Oxacycle / Oxane
Molecular Framework
Aliphatic heteropolycyclic compounds
External Descriptors
cineole (CHEBI:27961)
Affected organisms
  • Humans and other mammals

Chemical Identifiers

UNII
RV6J6604TK
CAS number
470-82-6
InChI Key
WEEGYLXZBRQIMU-WAAGHKOSSA-N
InChI
InChI=1S/C10H18O/c1-9(2)8-4-6-10(3,11-9)7-5-8/h8H,4-7H2,1-3H3/t8-,10+
IUPAC Name
(1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane
SMILES
C[C@@]12CC[C@@H](CC1)C(C)(C)O2

References

General References
  1. Bastos VP, Gomes AS, Lima FJ, Brito TS, Soares PM, Pinho JP, Silva CS, Santos AA, Souza MH, Magalhaes PJ: Inhaled 1,8-cineole reduces inflammatory parameters in airways of ovalbumin-challenged Guinea pigs. Basic Clin Pharmacol Toxicol. 2011 Jan;108(1):34-9. doi: 10.1111/j.1742-7843.2010.00622.x. Epub 2010 Aug 16. [Article]
KEGG Drug
D04115
KEGG Compound
C09844
PubChem Compound
2758
PubChem Substance
46506161
ChemSpider
21111689
RxNav
21116
ChEBI
27961
ChEMBL
CHEMBL1231862
PharmGKB
PA449555
Guide to Pharmacology
GtP Drug Page
PDBe Ligand
CNL
Wikipedia
Eucalyptol
PDB Entries
1t2b / 3be0 / 4fmx / 4fyz / 4l6g / 4l77 / 4lht
MSDS
Download (74.3 KB)

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount
4CompletedPreventionHealthy Subjects (HS)1
3Unknown StatusTreatmentCough1
2RecruitingPreventionNeisseria Gonorrhoeae Infection1
Not AvailableCompletedNot AvailableAcute rhino-sinusitis / Bronchitis / Chronic Sinusitis1
Not AvailableRecruitingNot AvailableCommunity Acquired Pneumonia (CAP)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
OintmentNasal
LiquidDental
MouthwashOral
MouthwashBuccal
LotionTopical
SprayTopical
PowderTopical
SolutionRespiratory (inhalation)
LiquidTopical
CreamTopical
MouthwashBuccal; Oral
LiquidIntramuscular
SuppositoryRectal
Capsule
GelTopical
LiquidTopical1.2 g/100mL
OintmentTopical
RinseOral
LozengeOral
SolutionTopical
MouthwashDental; Oral
SprayOral
LiquidOral
EmulsionTopical
OilTopical0.7 g/50g
CapsuleOral
OilTopical
MouthwashDental
Capsule, gelatin coatedOral
LiquidRespiratory (inhalation)
SolutionOral
Prices
Not Available
Patents
Not Available

Properties

State
Liquid
Experimental Properties
PropertyValueSource
melting point (°C)1.5 °CPhysProp
boiling point (°C)176.4 °CPhysProp
water solubility3500 mg/L (at 21 °C)YALKOWSKY,SH & DANNENFELSER,RM (1992)
logP2.74GRIFFIN,S ET AL. (1999)
Predicted Properties
PropertyValueSource
Water Solubility0.0225 mg/mLALOGPS
logP3.36ALOGPS
logP2.35Chemaxon
logS-3.8ALOGPS
pKa (Strongest Basic)-4.2Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count1Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area9.23 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity45.86 m3·mol-1Chemaxon
Polarizability18.54 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.988
Blood Brain Barrier+0.9842
Caco-2 permeable+0.7609
P-glycoprotein substrateSubstrate0.5435
P-glycoprotein inhibitor INon-inhibitor0.6374
P-glycoprotein inhibitor IINon-inhibitor0.6455
Renal organic cation transporterNon-inhibitor0.7847
CYP450 2C9 substrateNon-substrate0.8132
CYP450 2D6 substrateNon-substrate0.7839
CYP450 3A4 substrateSubstrate0.5962
CYP450 1A2 substrateNon-inhibitor0.7719
CYP450 2C9 inhibitorNon-inhibitor0.7571
CYP450 2D6 inhibitorNon-inhibitor0.95
CYP450 2C19 inhibitorNon-inhibitor0.658
CYP450 3A4 inhibitorNon-inhibitor0.9395
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9399
Ames testNon AMES toxic0.9574
CarcinogenicityNon-carcinogens0.7856
BiodegradationNot ready biodegradable0.8549
Rat acute toxicity1.8144 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8743
hERG inhibition (predictor II)Non-inhibitor0.7089
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0f79-3900000000-207d29106cfe3c54c018
Mass Spectrum (Electron Ionization)MSsplash10-0536-9200000000-aa52695ff4a2c1313e0b
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-0900000000-d481148e26447211338e
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-0900000000-a54b2adeda330d15fd27
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-0900000000-e9c7c0e6b576a23d244c
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-0900000000-5deec8995c432ff9d8c3
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-0900000000-20548748424de9aa6d15
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-052r-0900000000-f2f636a07e006bc2d898
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-138.77718
predicted
DeepCCS 1.0 (2019)
[M+H]+133.3374801
predicted
DarkChem Lite v0.1.0
[M+H]+141.17274
predicted
DeepCCS 1.0 (2019)
[M+Na]+133.1899801
predicted
DarkChem Lite v0.1.0
[M+Na]+147.40157
predicted
DeepCCS 1.0 (2019)

Drug created at June 13, 2005 13:24 / Updated at September 28, 2021 21:54